James N. Woody, M.D., Ph.D has more than 25 years of pharmaceutical research and management expertise.
He has served as our Chief Executive Officer and as a director since the closing of the business combination in November 2020. Dr. Woody has served as the CEO of 180 since July 2020, and as a director of 180 Life Sciences since September 2020.
Dr. Woody was a founder and served as Chairman of the Board of Directors for Viracta Pharmaceuticals, a lymphoma therapeutic company (2014 to 2020). With the company undergoing a reverse merger into a public company, he resigned his Board member position and continues as a Board observer.
He has served in a variety of health and management roles including as President of Roche Bioscience, and CSO and Senior Vice President of R&D for Centocor.
At Centocor, Jim was part of the team that discovered Remicade, used to treat arthritis and which is now one of the best-selling drugs in the world.
He served as Commanding Officer and Director at the US Naval Medical Research and Development Command in Bethesda, Maryland.
In this role he was responsible for the surveillance, detection and therapy for all biologic warfare agents and infectious diseases in the First Gulf War; he was awarded the US Navy Legion of Merit for his service.
He holds an MD from Loma Linda University, and trained in pediatric immunology at Duke University and Boston Children’s Hospital (Harvard).
He further holds a PhD in Immunology from the University of London and has co-authored more than 140 publications.
What is James N. Woody's net worth?
The estimated net worth of James N. Woody is at least $3,945.16 as of May 18th, 2023. Dr. Woody owns 2,204 shares of 180 Life Sciences stock worth more than $3,945 as of April 26th. This net worth estimate does not reflect any other assets that Dr. Woody may own. Additionally, Dr. Woody receives a salary of $617,770.00 as CEO at 180 Life Sciences. Learn More about James N. Woody's net worth.
How old is James N. Woody?
What is James N. Woody's salary?
How do I contact James N. Woody?
Has James N. Woody been buying or selling shares of 180 Life Sciences?
James N. Woody has not been actively trading shares of 180 Life Sciences during the past quarter. Most recently, on Thursday, May 18th, James N. Woody bought 2,105 shares of 180 Life Sciences stock. The stock was acquired at an average cost of $19.57 per share, with a total value of $41,194.85. Following the completion of the transaction, the chief executive officer now directly owns 2,204 shares of the company's stock, valued at $43,132.28. Learn More on James N. Woody's trading history.
Who are 180 Life Sciences' active insiders?
Are insiders buying or selling shares of 180 Life Sciences?
In the last year, 180 Life Sciences insiders bought shares 4 times. They purchased a total of 3,274 shares worth more than $65,380.52. The most recent insider tranaction occured on May, 31st when Director Jr. Donald A Mcgovern bought 526 shares worth more than $11,493.10. Insiders at 180 Life Sciences own 4.1% of the company.
Learn More about insider trades at 180 Life Sciences. Information on this page was last updated on 5/31/2023.
